Sensitive New Assay System for Serum Wisteria floribunda Agglutinin-Reactive Ceruloplasmin That Distinguishes Ovarian Clear Cell Carcinoma from Endometrioma
article
OA: closed
CC0
AI-generated summary
This study developed a highly sensitive and specific immunoassay using mutant WFA to measure WFA-reactive ceruloplasmin, effectively distinguishing ovarian clear cell carcinoma from endometrioma.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
agglutinin (WFA)-reactive ceruloplasmin (CP) is a candidate marker for ovarian clear cell carcinoma (CCC) reported in our previous paper. Herein, a new measurement system was developed to investigate its potential as a serum marker for CCC. Site-specific glycome analysis using liquid chromatography/mass spectrometry showed that WFA-CP from CCC binds to WFA via the GalNAcβ1,4GlcNAc (LDN) structure. We used mutant recombinant WFA (rWFA), which has a high specificity to the LDN structure, instead of native WFA, to increase the specificity of the serum sample measurement. To improve the sensitivity, we used a surface plasmon field-enhanced fluorescence spectroscopy immunoassay system, which is approximately 100 times more sensitive than the conventional sandwich enzyme-linked immunosorbent assay system. With these two improvements, the specificity and sensitivity of the serum rWFA-CP measurement were dramatically improved, clearly distinguishing CCC from endometrioma, from which CCC originates. This rWFA-CP assay can be used clinically for the serodiagnosis of early-stage CCC, which is difficult to detect with existing serum markers.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
References (35)
- Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review via openalex
- Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts via openalex
- Origin of clear cell carcinoma: nature or nurture? via openalex
- doi:10.1186/s13048-019-0497-1 via openalex
- doi:10.1158/0008-5472.can-03-2551 via openalex
- doi:10.1038/s41598-019-53052-1 via openalex
- doi:10.1038/nbt829 via openalex
- doi:10.1038/srep01065 via openalex
- doi:10.1016/j.humpath.2011.03.003 via openalex
- doi:10.1080/14789450.2018.1419066 via openalex
- doi:10.1093/glycob/cwab060 via openalex
- doi:10.1016/j.ijgo.2013.10.001 via openalex
- doi:10.1007/s13361-018-1938-6 via openalex
- doi:10.1111/j.1742-4658.2009.07430.x via openalex
- doi:10.1007/s10147-021-01914-y via openalex
- doi:10.3322/caac.21654 via openalex
- doi:10.1002/pmic.201400443 via openalex
- doi:10.1021/ac503735e via openalex
- doi:10.1159/000479006 via openalex
- doi:10.1074/jbc.m116.750463 via openalex
- doi:10.1007/s10534-019-00189-1 via openalex
- doi:10.1016/j.ab.2005.10.036 via openalex
- doi:10.1021/pr401109n via openalex
- doi:10.1016/j.ygyno.2006.09.028 via openalex
- doi:10.3802/jgo.2020.31.e45 via openalex
- doi:10.1038/sj.emboj.7601735 via openalex
- doi:10.1002/hep.23654 via openalex
- doi:10.1006/gyno.1998.5071 via openalex
- doi:10.1093/glycob/cwx038 via openalex
- doi:10.3390/ijms18020261 via openalex
- doi:10.1021/pr400986t via openalex
- doi:10.1038/nature14410 via openalex
- doi:10.1371/journal.pone.0091079 via openalex
- doi:10.1002/cncr.24152 via openalex
- doi:10.1373/clinchem.2010.157073 via openalex
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-05-13T19:38:49.755926+00:00
- pubmed
- last seen: 2026-05-13T22:24:03.506079+00:00
License: CC0
· commercial use OK